analysis of Ophthalmic Images to quantify Spaceflight-Associated Neuro-ocular measures..

NASA/NSSC has awarded a sole-source contract under FAR Part 13 and FAR 12.102(a) to the University of California, San Diego, for the analysis of ophthalmic imaging data to quantify changes associated with Spaceflight-Associated Neuro-ocular Syndrome. The contract, identified by solicitation number 80NSSC26938183Q, has a base performance period from August 1, 2026, to July 31, 2028, with an optional one-year extension through July 31, 2029. Work will be performed primarily at UC San Diego, with oversight and acceptance conducted by NASA at the Johnson Space Center in Houston, Texas. The contractor is required to analyze 25 electroretinography (ERG), 25 optical coherence tomography angiography (OCT-A), and 3 intravenous fluorescein angiography (IVFA) datasets, delivering detailed interpretations including PhNR amplitude quantification, perfusion and vessel density maps, flow void analysis, and retinal blood barrier assessments. These deliverables will support NASA’s Human Research Program’s mission to understand the effects of spaceflight on vision and ocular health. The solicitation requires a written capability statement and Statement of Work as attachments, with correspondence must reference the solicitation number in the subject line to ensure proper tracking. No competitive evaluation factors were applied due to the sole-source nature of the award, and no pricing, CLINs, or contract value details are included, consistent with a non-competitive procurement under FAR 13. No packaging, marking, or FOB requirements are applicable as the work involves digital data analysis, not physical delivery. The only explicitly included contract clause is NASA FAR Supplement 1852.215-84, which provides access to the NASA Ombudsman. Submission is due by 4:00 a.m. Central Standard Time on July 23, 2026, and must be delivered in writing without oral communications. Neither socioeconomic status, unique entity identifiers, security clearances, nor organizational conflict of interest disclosures are specified in the documentation.